par Vermorken, Jan Baptist;ten Bokkel Huinink, Wim;Kobierska, A;van der Burg, Maria;Forni, Mario;Piccart-Gebhart, Martine 
;van der Putten, E
Référence Oncology, 57, 1, page (10-16)
Publication Publié, 1999-07
;van der Putten, ERéférence Oncology, 57, 1, page (10-16)
Publication Publié, 1999-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Vermorken, Jan Baptist; ten Bokkel Huinink, Wim; Kobierska, A; van der Burg, Maria; Forni, Mario; Piccart-Gebhart, Martine; van der Putten, E |
| Informations sur la publication: | Oncology, 57, 1, page (10-16) |
| Statut de publication: | Publié, 1999-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Antibiotics, Antineoplastic -- administration & dosage | |
| Antibiotics, Antineoplastic -- adverse effects | |
| Antibiotics, Antineoplastic -- therapeutic use | |
| Antineoplastic Agents -- therapeutic use | |
| Cisplatin -- therapeutic use | |
| Drug Administration Schedule | |
| Epirubicin -- administration & dosage | |
| Epirubicin -- adverse effects | |
| Epirubicin -- therapeutic use | |
| Female | |
| Humans | |
| Leukopenia -- chemically induced | |
| Middle Aged | |
| Ovarian Neoplasms -- drug therapy | |
| Thrombocytopenia -- chemically induced | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase I | |
| Journal Article | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0030-2414 |
| info:pii/ocl57010 | |
| info:pmid/10394119 |
